Research map: Treatment outcomes maintained in Hunter syndrome patients: a case series on switching from idursulfase to idursulfase beta in Belarus

Back to the article

Papers in this map

  1. The CARE guidelines: consensus-based clinical case reporting guideline development · Joel Joseph Gagnier · 2013 · 730 citations · Cited by this paper
  2. Patient leadership and partnerships accelerate therapies for SCN8A and other developmental and epileptic encephalopathies · 2025 · Related
  3. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome) · Joseph Muenzer · 2006 · 595 citations · Cited by this paper
  4. Health services interventions to improve the quality of care in rare disease: a scoping review · 2024 · Related
  5. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy · James Edmond Wraith · 2007 · 538 citations · Cited by this paper
  6. Paving the way toward treatment solutions for CTNNB1 syndrome: a patient organization perspective · 2025 · Related
  7. The role of enzyme replacement therapy in severe Hunter syndrome—an expert panel consensus · Joseph Muenzer · 2011 · 113 citations · Cited by this paper
  8. Hutchinson–Gilford progeria syndrome: unraveling the genetic basis, symptoms, and advancements in therapeutic approaches · 2024 · Related
  9. Long‐term experience with enzyme replacement therapy (ERT) in MPS II patients with a severe phenotype: an international case series · Christina Lampe · 2014 · 72 citations · Cited by this paper
  10. Roadmap to advance therapeutics for SYNGAP1 -related disorder: a patient organization perspective from SynGAP Research Fund · 2025 · Related
  11. Mucopolysaccharidoses · Rolando Cimaz · 2013 · 65 citations · Cited by this paper
  12. Patient organization perspective: a research roadmap for Okur-Chung Neurodevelopmental Syndrome · 2024 · Related
  13. Differences in MPS I and MPS II Disease Manifestations · Christiane S. Hampe · 2021 · 55 citations · Cited by this paper
  14. Successful use of an eye gaze AAC communication board by a young adult with advanced Sanfilippo Syndrome (MPS IIIA): Case report · 2024 · Related
  15. Comparative study of idursulfase beta and idursulfase in vitro and in vivo · Chihwa Kim · 2016 · 41 citations · Cited by this paper
  16. The use of art as a creative research method to understand psychosocial care needs for children with rare diseases · 2024 · Related
  17. Mucopolysaccharidoses seen in adults in rheumatology · Stéphane Mitrovic · 2017 · 27 citations · Cited by this paper
  18. Hemophagocytic lymphohistiocytosis as the initial manifestation of bone marrow failure in a child with a TERC variant telomere biology disorder · 2025 · Related
  19. Enzyme replacement therapy for the treatment of Hunter disease: A systematic review with narrative synthesis and meta-analysis · Philip Erick Wikman Jorgensen · 2020 · 20 citations · Cited by this paper
  20. Patient-advocate-led global coalition adapting fit-for-purpose outcomes measures to assure meaningful inclusion of DEEs in clinical trials · 2024 · Related
  21. The diagnosis and management of mucopolysaccharidosis type II · Shao-Jia Mao · 2024 · 14 citations · Cited by this paper
  22. Enzyme replacement combinational therapy: effective treatments for mucopolysaccharidoses · Azam Safary · 2021 · 9 citations · Cited by this paper
  23. Study on the disease burden of patients with mucopolysaccharidosis type II in China · Yuan Ni · 2024 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)